MedTrace Logo

Safety and Efficacy of Gabapentin in Diabetic Peripheral Neuropathy

NCT00712439 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 147

Last updated 2011-06-08

No results posted yet for this study

Summary

The purpose of this study is to determine whether a new Gabapentin tablet, is safe and effective for the treatment of painful diabetic peripheral neuropathy.

Conditions

  • Diabetic Peripheral Neuropathy

Interventions

DRUG

Gabapentin Extended Release tablets

DRUG

Placebo

Sponsors & Collaborators

  • Depomed

    lead INDUSTRY

Principal Investigators

  • Rekha Sathyanarayana · Depomed

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2006-11-30
Completion
2006-12-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00712439 on ClinicalTrials.gov